Article Correctness Is Author's Responsibility: Study shows sharp decline in cancer screenings, diagnoses during the first COVID-19 surge

(Dana-Farber Cancer Institute) In one of the first studies to examine the impact of the COVID-19 pandemic on cancer diagnoses, researchers at Dana-Farber/Brigham and Women's Cancer Center document a substantial decline in cancer and precancer diagnoses at the Northeast's largest health care system during the first peak of the pandemic because of a drop in the number of cancer screening tests performed.